In the latest trading session,, 0.55 million Enveric Biosciences Inc (NASDAQ:ENVB) shares changed hands as the company’s beta touched 0.46. With the company’s most recent per share price at $1.36 changed hands at -$0.05 or -3.90% at last look, the market valuation stands at $3.35M. ENVB’s current price is a discount, trading about -749.26% off its 52-week high of $11.55. The share price had its 52-week low at $1.01, which suggests the last value was 25.74% up since then. When we look at Enveric Biosciences Inc’s average trading volume, we note the 10-day average is 0.22 million shares, with the 3-month average coming to 241.22K.
Enveric Biosciences Inc (NASDAQ:ENVB) trade information
Instantly ENVB was in red as seen in intraday trades today. With action 7.54%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -80.78%, with the 5-day performance at 7.54% in the green. However, in the 30-day time frame, Enveric Biosciences Inc (NASDAQ:ENVB) is 8.40% up. Looking at the short shares, we see there were 0.27 million shares sold at short interest cover period of 1.49 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 57.47%.
ENVB Dividends
Enveric Biosciences Inc is expected to release its next quarterly earnings report on 2025-Mar-28.
Enveric Biosciences Inc (NASDAQ:ENVB)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 8.99% of Enveric Biosciences Inc shares while 14.17% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 15.57%. There are 14.17% institutions holding the Enveric Biosciences Inc stock share, with ADVISORSHARES INVESTMENTS LLC the top institutional holder. As of 2024-06-30, the company held 7.9233% of the shares, roughly 0.32 million ENVB shares worth $0.19 million.
GEODE CAPITAL MANAGEMENT, LLC holds the second largest percentage of outstanding shares, with 1.1161% or 44659.0 shares worth $27688.0 as of 2024-06-30.
Among Mutual Funds, the top two as of Jun 30, 2025 were AdvisorShares Trust-AdvisorShares Psychedelics ETF and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . With 103.68 shares estimated at $0.14 million under it, the former controlled 4.19% of total outstanding shares. On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund held about 0.51% of the shares, roughly 12.59 shares worth around $17003.0.
